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Oxidative stress, characterized by overproduction of reactive oxygen species (ROS), is a major fea-
ture of several pathological states. Indeed, many cancers and neurodegenerative diseases are accom-
panied by altered redox balance, which results from dysregulation of nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase. In this review, we consider the role of the intracellular
chloride channel 1 (CLIC1) in microglial cells during oxidative stress. Following microglial activa-
tion, CLIC1 translocates from the cytosol to the plasmamembrane where it promotes a chloride con-
ductance. The resultant anionic current balances the excess charge extruded by the active NADPH
oxidase, supporting the generation of superoxide by the enzyme. In this scenario, CLIC1 could be
considered to act as both a second messenger and an executor.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. CLIC1 and oxidative stress
Reactive oxygen species (ROS), may act as compounds that im-
pair cell and protein function, but they may also act as second mes-
sengers in cellular processes that involve changes in the cellular
redox state, including migration, differentiation, and cell replica-
tion. Indeed, many proteins have redox-sensitive motifs, such as
cystein residues and metal co-factors, that are altered by redox
state. Kinases such as mitogen-activated protein kinase (MAPK),
protein kinase C (PKC) and protein kinase B (PKB), are also acti-
vated by cell oxidation [1]. Cell homeostatic mechanisms establish
a balance between ROS production and their removal by antioxi-
dant systems. The overwhelming of antioxidant defences by ROSchemical Societies. Published by E
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raimo).generation results in a condition of oxidative stress. Several path-
ological conditions are characterized by changes in cellular redox
state, in particular chronic inﬂammatory states, oncologic condi-
tions [2,3] and degenerative process [4–6].
Alzheimer’s disease (AD) is a progressive neurodegenerative dis-
ease that affects millions of people every year and is the main cause
of dementia in the elderly for which an effective therapy is yet to be
found. The AD brain is characterized by the presence of intraneuro-
nal neuroﬁbrillary tangles constituted by the hyperphosphorilated
form of the cytoskeleton protein Tau and deposits of the amyloid
beta (Ab) protein, also known as senile plaques [7]. Ab is the aber-
rant form of the transmembrane protein APP (amyloid precursor
protein), resulting from the cleavage by gamma and beta secretases
[8]. Although for decades the presence of amyloid plaques in the
central nervous system (CNS) have been thought to be the main
causative factor for neurodegeneration, recent studies propose that
soluble oligomers can be more dangerous for neurons than the ac-
tual plaques [9]. Indeed, the neurological deﬁcits in AD patients do
not always correlate with the location of amyloid plaques, but often
appear in regions of the brain that are distinct from the sites of the
plaques [9]. Recent work suggests that in AD neurodegeneration
might be mainly due to the hyper activation of microglial cells in
presence of oligomers of Ab in the CNS [10].
Microglia represent the immune effector cells of the CNS [11],
where they play an important role protecting neurons from bacte-
rial infections, inﬂammation, trauma, ischemic damage etc. In theirlsevier B.V. All rights reserved.
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allowing for a quick reaction to injury or pathogens. Exposed to
an insult these cells become activated and undergo several changes
in their morphology and their electrophysiological characteristics.
Activated microglia are characterized by a round shape, active cell
proliferation, migration in the site of infection or injury, phagocy-
tosis of bacteria or cell debris and severe production of pro-inﬂam-
matory molecules and growth factors such as tumor necrosis factor
alpha (TNFa), nitrites, ROS and cytokines [11]. Activated microglia
also show altered expression of potassium, proton, sodium, cal-
cium and chloride currents [12–14]. In the last decade, microglia
have been proposed to play a crucial role in several neurodegener-
ative diseases [6,11]. In AD, Ab oligomers interact with receptors
on the cell surface of microglia cells that recognize the structurally
aberrant protein as an intruder [11,15]. In this view, microglia ap-
pear to have a neuroprotective role, acting as faithful sentinels of
the brain. However, in neurodegenerative diseases they are hyper
activated, which results in neurotoxic effects [11]. This double
and conﬂicting role of microglia is extremely evident in AD. The
chronic microglia activation caused by the increased concentration
of oligomers at ﬁrst and by the senile plaques later is responsible
for a continuous production of neurotoxic molecules like TNFa,
interleukin 6 (IL6), IL1, nitric oxide (NO), ROS and others. On theFig. 1. Chloride intracellular channel 1 (CLIC1) protein translocates to the cell membrane
CLIC1-eGFP before (left) and after (right) stimulation with 5 lM Ab25–35. The insets s
ﬂuorescence in the plasma membrane after stimulation with Ab. (b) A CLIC1-eGFP transfe
colocalization of green and red ﬂuorescence in the membrane after treatment (right). Ov
within the cell membrane region after Ab exposure. (c) BV2 cells transfected with CLIC1
with an antibody speciﬁcally directed against the ﬂag (middle panel, red). In the right pa
Ab. (d) BV2 cells are incubated with an antibody directed against the N-terminus of the e
the plasma membrane due to the translocation of CLIC1 (right panel), compared to contr
extracellular N-terminus of CLIC1; untreated cells exhibited no immunoreactivity (left)
membrane localization of CLIC1. For the untreated cell (left), the transmitted light image
but is absent. Scale bars 20 lm. Fig. 1 from Milton et al., 2008.other hand, microglia, together with astrocytes, have a prominent
role in phagocytic activity, which serves to eliminate Ab deposits.
Thus, there is a sensitive balance between the neuroprotective
role of microglia in the removal of damaging stimuli (including
amyloid deposits) through phagocytosis, and the detrimental ef-
fects of TNFa, ROS and nitrite production on neurons [11]. In AD
this balance is dangerously impaired.
Finding a mechanism that could limit the production of neuro-
toxic substances, without impairing the phagocytic activity of
microglia, could be an interesting and valuable strategy to delay
the inexorable progression of many neurodegenerative diseases
[15].
Our laboratory has found a promising candidate to control this
mechanism. We have shown that in microglia stimulated by Ab,
the chloride intracellular channel 1 (CLIC1) is over expressed and
its presence on the nucleus and on the plasma membrane is aug-
mented (Fig. 1) [16]. The blockade of CLIC1 functional expression
with speciﬁc inhibitors (Fig. 2), or its knock down by small interfer-
ence RNA (siRNA), limits the detrimental effects due to the over
activation of microglia cells, impairing the production of nitrites
and ROS [16,17] that are so harmful for neurons (Fig. 3). Thus, in
these conditions, neurodegeneration may be limited without
affecting the phagocytic ability of microglia [15]. Membrane pro-during acute exposure to amyloid beta (Ab) peptides. (a) BV2 cells transfected with
how the intensity proﬁles of ﬂuorescence of the cell. It is evident an increase of
cted cell labeled with the membrane marker DiIC12 (red) treated with Ab, showing
erall, CLIC1-GFP/DiIC12 ﬂuorescence showed a signiﬁcant increase in colocalization
-eGFP carrying a m2-ﬂag at the N-terminus (left panel, green) are immunostained
nel is shown the merged image, before (upper) and after (bottom) stimulation with
ndogenous protein. After stimulation with Ab there is an increase of ﬂuorescence in
ol (left panel). (e) Unpermeabilized BV2 cells were probed using an antibody to the
, whereas the resulting immunoreactivity in Ab-treated cells (right) conﬁrmed the
has been added to delineate the cell borders where ﬂuorescence might be expected
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Fig. 2. Current/voltage relationship for chloride intracellular channel 1 (CLIC1) protein. (a) On the left are shown single-channel current traces obtained in tip dip
experiments in equimolar (140 mM) KCl at different applied voltages. The I/V relationship is shown on the right. (b) Comparison of CLIC1 single-channel properties in primary
rat microglia and in the BV2 cell line. On the top single-channel current traces recorded at different membrane potentials from primary microglia (top left) and BV2 cells (top
right). The I/V plot from microglia and BV2 cells is shown on the bottom. From Novarino 2004 (extracellular solution, in mM: 140 NaCl, 5 KCl, 1 MgCl2, 2.5 CaCl2, 10 HEPES,
and 10 glucose, pH 7.3). (c) Amyloid beta (Ab) stimulation alters CLIC1 single-channel activity in BV2 cells. On the top sample traces recorded in untreated BV2 cells (left) and
in cells stimulated with 30 lM Ab for 24 h (right) at 20 mV membrane potential. On the bottom, outside-out single-channel block by 10 lM IAA94 on both control and
stimulated BV2 cells. From Novarino 2004 (pipette’s solution, in mM: 10 NaCl, 130 K-Asp, 2 MgCl2, 1.3 CaCl2, 10 HEPES, and 10 EGTA, pH 7.3. Bath solution in mM: 140 NaCl, 5
KCl, 1 MgCl2, 2.5 CaCl2, 10 HEPES, and 10 glucose, pH 7.3. (d) Ab peptide increases CLIC1-mediated membrane chloride current in microglia. In the upper left panel sample
traces of BV2 cells in whole cell conﬁguration, treated as indicated. On the top right current–voltage relationships of the IAA94- (squares) and 4,40-diisothiocyanatostilbene-
2,20-disulfonate (DIDS)-(circles) sensitive currents. Both currents show reversal potentials close to the Cl equilibrium potential in those given experimental conditions
(45.4 ± 2.7 mV and 42.7 ± 2.2 mV, respectively). In the bottom panel time course of the BV2 microglial cell membrane current amplitude measured at a voltage step from
50/+50 mV, delivered every 10 s. Starting from a steady value, the cell was perfused with Ab25–35. After 5–15 min, the current increased, reaching a plateau over 10–20 min.
Application of IAA94 reduced the current amplitude which was further reduced by 200 lM DIDS. The opposite sequence of chloride channel blockers was then followed,
showing that IAA94 and DIDS act on different targets. Intracellular solution contained in mM: 20 TEACl, 120 TEACH3SO4, 10 HEPES, 10 glucose, pH 7.2; extracellular solution
contained, in mM: 90 NaCl, 40 TEACl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 glucose, pH 7.35. Fig. 2a from Warton 2002, 2b and 2c form Novarino 2004, 2d from Milton 2008.
2078 S. Averaimo et al. / FEBS Letters 584 (2010) 2076–2084teins have always been particularly useful therapeutic targets,
especially for the development of drugs acting on the CNS and car-
diovascular system. Due to its functional expression and modula-
tion CLIC1 may be such a potential target.
2. CLIC1: history, molecular structure and cellular localization
CLIC1 is a 241 amino acid protein and it is part of a recently
identiﬁed family of seven members, highly conserved among sev-
eral species and with wide tissue and subcellular distribution in
mammalian cells [18]. CLIC1 homologues are also found in inverte-
brates [19] and plants [20]. CLIC1 was ﬁrst cloned in 1997 from ahuman monocytic cell line activated by the phorbol ester, phorbol
12-myristate 13 acetate (PMA) [21]. CLIC1 exists usually in a solu-
ble form in the cytoplasm and nucleoplasm, but following several
stimuli undergoes major structural changes and inserts in lipid
membranes, where it acts as a chloride-selective ion channel. Cell
oxidation seems to be the most important stimulus controlling the
transition of CLIC1 between these two forms [22,23]. A number of
experiments have demonstrated that in reduced conditions the
localization of the protein is mainly cytoplasmic. On the contrary,
oxidation increases its presence in the plasma membrane [22]. Re-
cent studies demonstrate that CLIC1 has a binding site for the re-
duced form of glutathione (GSH) in its N-terminal domain
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Fig. 3. Chloride intracellular channel 1 (CLIC1) is required for amyloid beta (Ab)-
induced microglial ROS production. (a) Perfusion of primary microglia with Ab
induces an increase of the membrane current (left) and an increase in ROS
production (right), measured as an increase in the rate of change of ﬂuorescence
derived from hydroethidium (HEt) oxidation (triangles). Blockade of CLIC1 by IAA94
(50 lM) decreases the chloride current (left) and prevented the Ab-induced ROS
production (right, circles). (b) Suppression of CLIC1 expression with siRNA reduces
the Ab-stimulated current compared to control cells (left) and the rate of Ab-
induced ROS generation (right) measured as HEt oxidation. (c) Membrane potential
measurements during Ab exposure. Shown is an example in which a microglial cell
depolarized from 75 mV to 43 mV after perfusion with Ab25–35 (50 lM); after
reaching a plateau, addition of 50 lM IAA94 prompted a further 25 mV depolar-
ization. The effect of the chloride channel blocker was completely reversible (left).
In a similar experiment from another cell, 3 mM zinc had no effect on the
membrane depolarization caused by Ab. The effect of IAA94 was still evident (right).
Figure 3 from Milton 2008. In current-clamp conﬁguration, the bath solution was
composed of (in mM) 145 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 glucose, pH
7.35, and we ﬁlled the electrode with (in mM) 20 KCl, 120 KAsp, 10 HEPES, 10
glucose, pH 7.2.
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that the protein undergoes upon oxidation, GSH detaches from
its binding site that is consequently rearranged and, together with
the amino terminal of the protein, probably constitutes the hydro-
phobic region that interacts with the cell membrane. Thus, several
lines of evidence indicate that CLIC1 acts as a sensor of cell oxida-
tion [16,17,22,26]. Moreover, the membrane insertion process of
CLIC1 is also regulated by intracellular pH. Experiments in artiﬁcial
membranes have shown that the probability of CLIC1 insertion into
lipid membranes increases not only in acidic pH [27] but also in ba-
sic conditions [28].
The structure of the soluble form of CLIC1 was resolved in 2001
by Harrop and colleagues [24]. The N-terminal and the C-terminal
domains are connected by a proline rich region between cysteine
89 and asparagine 100. In this region proline 91 seems to have
an important role due to its change from cis to trans conﬁguration
between the soluble and the transmembrane form of the protein.
The crystal structure of the membrane-inserted form has not beensolved yet. Bioinformatics studies and digestion experiments with
proteinase K on another member of the CLIC family, CLIC4, suggest
that the region between cysteine 24 and valine 46 is a putative
transmembrane domain. This region has the length and the hydro-
phobic characteristics necessary to cross the lipid bilayer. More-
over, the 22 amino acids stretch appears protected by proteinase
digestion, probably because is masked by the lipid membrane [24].
The mechanism by which CLIC1 inserts into biological mem-
branes is still not completely understood. In 2004, Littler proposed
a model to explain the association of CLIC1 with the lipid mem-
brane. This model suggests that in vitro CLIC1 undergoes structural
changes upon oxidation, exposing hydrophobic residues that pro-
mote the dimerization of the protein, minimizing contact with
the aqueous environment of the cytoplasm. Indeed, addition of
pro-oxidant compounds results in the appearance of dimers, com-
prising 2/3 of the total amount of protein. In vivo the hydrophobic
region could also act as a membrane-docking region, promoting
the insertion of the CLIC1-dimer into membranes. The outcome,
being either insertion into the membrane or formation of dimers,
could depend on the total amount of the protein in the cell. The
main structural difference between the monomeric and the di-
meric form of CLIC1 is the disappearance of beta-sheet structures.
Cystein 24 and maybe also 59 appear to be indispensible for the
transition to the dimeric form upon oxidation, probably because
the formation of an intermediate disulﬁde bridge between the
two residues stabilizes the dimeric form [22]. According to Littler’s
model oxidation is essential for the transition between the two
forms.
Recently Goodchild and colleagues [26] tried to clarify the
mechanism that causes CLIC1 insertion into membranes, suggest-
ing that the dimerization process that takes place during oxidation
is not necessary for the insertion of the protein into membranes. In
this model, CLIC1 monomer ﬁrst can interact by itself with the
membrane surface and successively the oxidation promotes the
structural changes that permit the protein to cross the membrane
and form a functional ion channel. This hypothesis is supported by
evidence showing that both monomeric and dimeric forms of
CLIC1 are able to form functional ion channels in artiﬁcial mem-
branes [22]. It is still unclear though how CLIC1 can interact with
the lipid membrane before oxidation if the docking-membrane
surface is masked as part of the GSH binding site.
When inserted in the plasma membrane, the protein exposes its
N-terminus to the extracellular side, whereas the C-terminus re-
mains on the intracellular side. Recombinant CLIC1 carrying a ﬂag
epitope at the amino terminus of the protein and overexpressed in
CHO (Chinese hamster ovary) cells show positivity only when the
anti-ﬂag antibody is added from the outside on intact cells. The
same procedure fails when the antibody is applied to cells transfec-
ted with the protein tagged at the C-terminus [29]. Cells transfec-
ted with CLIC1 tagged at the N-terminus show similar results in
microglia culture cell line BV2 [17].
CLIC1 was ﬁrst found to localize both on the nuclear envelope
and the plasma membrane of CHO cells transfected with CLIC1-
GST fusion protein using a speciﬁc antibody [21]. It has been dem-
onstrated that the protein inserted into the nuclear membrane has
the same biophysical features of the protein inserted into the plas-
ma membrane [29]. Further studies have demonstrated that the
subcellular localization of CLIC1 varies among different cell types.
For example, in non-polarized cells CLIC1 appears diffused
throughout the cytoplasm. In cell cultures of non-polarized cells
it is present either in its soluble or membrane-inserted form, and
the latter localizes primarily in the plasma membrane. In contrast,
in polarized cells CLIC1 is strongly present at the apical domain,
although in cell cultures of polarized cells it is not found in the
plasma membrane, but co-localizes with membrane vesicles, prob-
ably of the endocytic compartment [18]. Thus, we cannot rule out
2080 S. Averaimo et al. / FEBS Letters 584 (2010) 2076–2084that the subcellular distribution of CLIC1 is largely dependent on
the cell type or the different phases of the cell cycle. In monocytes
and in microglial cells, CLIC1 is mainly present in the cytoplasm of
untreated cells, but following an oxidative stimulus it translocates
and clearly co-localizes with the plasma membrane (Fig. 1b)
[16,17].3. Is CLIC1 an ion channel?
In more than 10 years since CLIC1 was discovered, the diatribe
about its functional expression is still controversial. For the major-
ity of the people who actively works on the protein properties,
CLIC1works as a chloride selective channel with the unique charac-
teristics to be transiently expressed on the membrane following
speciﬁc stimuli [16,17,28–30]. The arguments against the ion chan-
nel hypothesis are not trivial. Themain reasons concern the channel
structure. It is considered unlikely that a hydrophilic protein under-
goes a drastic change that allows the insertion into membrane and
the formation of an ion channel. Moreover, experiments in artiﬁcial
bilayers are considered to be too prone to artifacts and single-chan-
nel recordings from the cell membrane could reasonably be due to a
modulation by CLIC1 on other chloride channels resident in mem-
brane. In the latter case CLIC1 would work as a second messenger
or a functional additional subunit. Last but not least, a speciﬁc
blocker of CLIC1 permeability is not known and conventional chlo-
ride channel antagonists like 4,40-diisothiocyanatostilbene-2,20-
disulfonate (DIDS) or 4-acetamido-40-isothiocyanato-2,20-stilben-
edisulfonic acid (SITS) have no effect. Indanyloxyacetic acid 94,
R(+)-methylindazone, R(+)-[(6,7-dichloro-2-cyclopentyl-2,3-dihy-
dro-2-methyl-1-oxo-1H-inden-5-yl)-oxy]acetic acid (IAA94), niﬂu-
mic acid and 9-anthracene all down-regulate the current but they
are not very speciﬁc [27–29,31].
From the physiological point of view it is not crucial that CLIC1
acts directly as an ion channel. Down regulation of protein expres-
sion with siRNA or inhibition with IAA94 are effective in several
cellular processes [16,17]. However, understanding whether or
not the functional expression of the protein is actually an ion chan-
nel will require a more satisfactory pharmacological approach. In
view of CLIC1 as a therapeutic target, the possibility to interact
with the protein from the external side of the plasma membrane
would facilitate the development of new compounds.
In the last 10 years several research groups have demonstrated,
using different experimental approaches, that CLIC1 could realisti-
cally form an ionic pathway [16,21,23,27–30]. According to this
view, CLIC1 would be one example of an ion permeable protein
transiently expressed in the cell membrane. The mechanism of
protein docking and insertion into the lipid bilayer is still obscure.
The water soluble structure [22,24] must undergo a radical rear-
rangement to reach a plausible membrane spanning conformation
of the protein [22]. The current hypothesis proposes that the actual
pore would be formed by two or four CLIC1 single proteins. Follow-
ing changes in the redox state of the cell, the protein rearranges its
structure and exposes a large hydrophobic surface. The dimeric
conformation has been characterized in a previous work [22]. It
is more likely that the channel subunits come together during
the docking procedure and in this form they get inserted in the
membrane [22,24].
The biophysical properties of the presumed CLIC1 ion channel
were studied in artiﬁcial lipid bilayers [19,22–24,27,28,31,32], in
expression systems [29,30], in cell lines or in primary cultures
expressing the endogenous protein [16,17].
Working with the recombinant protein in artiﬁcial membrane
systems, we and others have demonstrated that the functional
expression of CLIC1 as an ion channel depends on oxidation
[23,27,28], pH [28,27] and lipid composition [23,32]. The channelreconstituted in artiﬁcial bilayer, in symmetrical 140 mM potas-
sium chloride, shows a conductance around 30 pS (Fig. 2a). The
conductance of the ion channel is strictly dependent on the chlo-
ride concentration. In cell attached experiments, where the inter-
nal chloride concentration is very low compared to the external
concentration, approximately 20 mM inside and 140 mM in the
extracellular solution, the conductance is 7 pS (Fig. 2b) [16]. Ion
selectivity of the ion channel has been previously measured by sev-
eral groups [23,31], showing the following permeability scale:
IP SCNP ClP NO23 P Br
P F [23], with an evident ion
selectivity of chloride versus potassium [31].
The only effective and reversible channel blocker so far identi-
ﬁed is IAA94, with an EC50 of 8.6 lM [28]. IAA94 seems to be quite
speciﬁc at a concentration of 50 lM (Fig. 2c) [16,17,30]. IAA94 has
very similar structure to the well known inhibitor of the GST pro-
tein family, ethacrynic acid [33]. A crystallographic study demon-
strated that the CLIC1 hydrophilic conformation can bind
glutathione in position 24 [22,24]. The same studies provide evi-
dence that IAA94 also has a binding site in the surrounding of
aa24. As we mentioned above, the putative membrane spanning
domain of CLIC1 protein is delimited between aa24 and aa46.
The idea is that the protein, in an oxidative environment, loses
the glutathione and rearranges its structure. After the insertion
of the putative transmembrane domain, the IAA94 binding site is
faced on the extracellular side, accessible to the channel blocker.
Although most groups working on CLIC1 function use the bi-
layer technique, the clearest evidence that CLIC1 could be a func-
tional ion channel have been obtained in cell expression systems.
Plasmids carrying the gene for CLIC1 allow the expression of the
wild type (WT) and mutated protein. Ion channel activity was re-
corded both in the nuclear and in the plasma membrane in CHO
cells after transfection [21,30]. CLIC1 was then tagged with a ﬂag
of eight amino acids alternatively at the COOH and on the NH2
ends. The expression of the fusion protein GFP-CLIC1 allowed
selection of CHO cells transfected with the construct. Using such
plasmids we demonstrated that CLIC1 protein not only docks the
membrane from the cytoplasmic side but it also spans the lipid bi-
layer. Furthermore, in single-channel patch-clamp experiments we
showed that CLIC1 exposes the amino terminus outside while the
carboxy terminus is cytoplasmatic [29]. The ionic current ﬂowing
through the chloride selective channel can be inhibited by the
anti-ﬂag antibody alternatively delivered to an inside-out patch,
if the ﬂag is at the COOH terminus, or to an outside-out experiment
in case the ﬂag is positioned at the NH2 terminus [29]. More re-
cently we characterized electrophysiologically two CLIC1 recombi-
nant proteins carrying a single point mutation in the putative
transmembrane domain (aa24–aa46). One mutant protein has
the Arginine 29 substituted by an Alanine. The latter replaced a Ly-
sine 37 in a second mutated protein. Both mutations were able to
change CLIC1 single-channel characteristics (Mazzanti, unpub-
lished results).
Accordingly, we are conﬁdent that we can answer positively the
question formulated in the title of this chapter. We are certainly
aware that conclusive prove will be the resolution of the mem-
brane spanning protein structure, but at the moment this opportu-
nity appears remote due to technical limitations.4. CLIC1 and oxidation: involvement of the protein in
tumorigenic processes and in neurodegenerative diseases
4.1. CLIC1 and tumors
It has been demonstrated that CLIC1 is involved in the regula-
tion of the cell cycle. CLIC1 is detected on the plasma membranes
of cells in the G2/M phase. During this period the current density is
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bition of CLIC1 function prolongs the mean time of the cell cycle in
cell culture [16,30]. It is well known that during the cell cycle there
are oxidative ﬂuctuations that lead the cells through all the phases
of the cell cycle [1]. So it is not surprising that CLIC1 is hyperacti-
vated in cancer cells which are in a highly proliferative state. CLIC1
is overexpressed in human gastric carcinoma [34], colorectal can-
cer [35] and gall bladder carcinoma [36]. CLIC1 appears to have a
main role in all the diseases that involve oxidative stress, including
tumors. The behavior of CLIC1, whichmigrates to the plasmamem-
brane in response to changes in the redox state of the cells, sug-
gests that CLIC1 should be explored as a potential therapeutic
target. One of the challenge in tumor treatments is the possibility
to target speciﬁcally the cancerous elements, without affecting
healthy cells. Non-speciﬁcity is one of the main problems of anti-
cancer treatments, and many therapeutic approaches are limited
by toxicity. It is in this view, that CLIC1 assumes a signiﬁcant role
as a potential target. Its transient expression on the plasma mem-
brane during oxidative peaks offers the protein as a unique func-
tional target during the tumorogenic process.
4.2. CLIC1 in neurodegenerative diseases
As we have mentioned above, the pathophysiology of several
neurodegenerative diseases involves oxidative stress. Although
the different forms of these pathological process are substantially
unrelated, oxidative stress represents a common ground shared
by most of them. The main source of oxidative products is the brain
intrinsic immune system. Activated microglia produce large
amounts of superoxide and related ROS through the activation of
the membrane nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase [37]. Recently, the involvement of oxidative
stress mediated by NADPH oxidase activity has been evaluated in
the pathogenesis of motoneuron disease (amyotrophic lateral scle-
rosis or ALS) [4]. It seems that ROS production generated by acti-
vated microglia kills already damaged motor neurons leading to
motoneuron degeneration and the symptoms of this disease. An
involvement of the NADPH oxidase has also been proposed in the
pathogenesis of Parkinson’s disease (PD). Dopaminergic neurons
co-cultured with microglia lacking the gene coding for the NADPH
oxidase are more resistant to rotenone-induced neuronal death [6].
Moreover, Thomas and colleagues [5] demonstrated a role of
microglia activated by alpha synuclein in PD. Alpha synuclein is
the peptide constituent of Lewy bodies that is released by degener-
ating dopaminerigic neurons. ROS production is stimulated by
incubation of microglia with aggregated alpha synuclein. As we
mentioned above, one of the causes of AD pathogenesis seems to
be microglial activation induced by Ab that promotes oxidative
stress and consequent neurodegeneration [7].
Several lines of evidence support the hypothesis of a fundamen-
tal role of CLIC1 protein in activated microglia. In a recent report,
Parachikova and colleagues showed that CLIC1 expression has a
60% increase in the hippocampus of mild/moderate AD dementia
patients [38]. Moreover, in a triple mutation AD mouse model
[39], CLIC1 is mainly localized in the plasma membrane of acti-
vated microglia [17]. In in vitro experiments, Ab stimulation of
either primary rat microglia or the microglial cell line BV2 causes
not only an up-regulation of the CLIC1 protein [16] but also a
change of the membrane anion permeability [17]. Patch-clamp sin-
gle-channel recordings associate the increase of membrane con-
ductance to the functional expression of CLIC1 in the membrane.
Channel activity is also directly regulated by Ab, which increases
its open probability and mean open time [16] (Fig. 2c). In co-cul-
ture hippocampus neurons and microglia cells it is evident the role
of CLIC1 in neuronal death. The overproduction of toxic com-
pounds is reduced in the presence of CLIC1 channel blockers[16]. Moreover, a speciﬁc CLIC1 siRNA drastically reduced the pro-
duction of TNFa [16] and ROS (Fig. 3) [17].5. NADPH oxidase and charge compensation mechanisms
The interaction of Ab with speciﬁc receptors on the surface of
microglia activates parallel intracellular signaling cascades that
converge to activate the NADPH oxidase [37]. This multimeric en-
zyme is made up of two transmembrane subunits, p22phox and
gp91phox, and four regulatory subunits: p67phox, p47phox,
p40phox, and the G-protein Rac. These last four components are
soluble in the cytoplasm and associate with the cell membrane fol-
lowing several stimuli, such as the enhancement of internal cal-
cium concentration, phosphorylation by protein kinases [40] and
changes in the temperature [41]. Once assembled, they constitute
the functional protein complex that produces the superoxide an-
ion, which is released extracellularly and used during the microg-
lial immune reaction. The family of the NADPH oxidase comprises
seven different members that are expressed in different tissues.
Microglia, like all phagocytic cells, express the NOX2 isoform
[42]. The NADPH oxidase produces ROS by transferring electrons
from the intracellular donor NADPH to extracellular oxygen, giving
rise to an outward ﬂow of negative charges that depolarizes the
plasma membrane [43–45]. It has been calculated that in the ab-
sence of a compensatory mechanism, an eosinophil at 37 C during
a respiratory burst would depolarize the cell to + 190 mV in less
than 20 ms [44]. NADPH oxidase function is strictly dependent
on the membrane potential, since depolarized voltages limit its
activity [44]. In human eosinophils ROS production, measured as
electron current mediated by the oxidase, is completely abolished
at + 200 mV [46]. The complete inhibition of ROS production would
constitute a high risk factor for brain defenses. On the other hand,
hyperpolarized microglia retain the best condition to generate
superoxide. To maintain a more negative potential there must be
an efﬁcient mechanism of charge compensation to counteract the
charge extruded by the oxidase. Thus, to balance this ‘‘leak” of neg-
ative charges that strongly depolarize the cell, a compensatory ﬂux
of ions has to take place. To prevent a strong depolarization the cell
must activate an inward ﬂow of negative charges or an outward
ﬂow of positive charges. Several ion currents have been proposed
to constitute the charge compensation mechanism for the NADPH
oxidase in a number of different cell types. In 2002, Reeves and col-
leagues proposed an involvement of potassium channels in the
charge compensation mechanism in neutrophils activated by PKC
agonists [47]. They measured the release of potassium ions from
vacuoles to the cytoplasm. The production of ROS was inhibited
by the presence of potassium channel blockers and it was subse-
quently restored following the addition of the speciﬁc potassium
ionophore valinomycin. However, this mechanism is still contro-
versial [48]. In 2006, Moreland and colleagues described an
involvement of the chloride current during NADPH oxidase activa-
tion by PMA in neutrophils. They found in the ClC3 channel a can-
didate for this role [49]. A different chloride permeability, the
swelling activated chloride channels was alternatively proposed
by Ahluwalia [50], although his data are strongly in conﬂict with
other existing data [51]. In Ahluwalia’s paper, in fact, neutrophils
stimulated by PMA do not show any proton current following the
activation of the oxidase, even though this mechanism has been
well characterized by several groups [52,53]. More recently De Si-
moni and colleagues [54] identiﬁed the charge compensatory cur-
rent as a depolarization-activated non-selective cation current
mediated by a novel non-selective cation channel. They proposed
that this channel acts in concert with potassium current mediated
by Kv1.3 channels, in rat microglia cells activated by lipopolysac-
charide (LPS). However, De Simoni’s experiments were performed
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minimize the involvement of CLIC1 in the oxidation process, due
to the dialysis of the cytoplasm and thus the leak of CLIC1, still
in its soluble form, preventing its insertion into the plasma mem-
brane. Nevertheless, the largest amount of data about NADPH oxi-
dase charge compensation in neutrophils and eosinophils point to
an involvement of proton channels as the most reliable candidate.
Several groups [40] have demonstrated that during cell stimulation
by PKC agonists the membrane potential of neutrophils and eosin-
ophils undergoes a very strong depolarization, reaching positive
potentials. In symmetrical pH, the proton current has an activation
threshold around +40 mV [55]. Thus, when these cells are acti-
vated, the depolarization allows an outward current sufﬁcient to
counteract the inward current mediated by the oxidase
[40,52,55]. Moreover, the accumulation of protons derived from
the oxidation of NADPH to NADP+ + H+ inside the cell favors the
electrochemical gradient for the proton current. Inhibition of pro-
ton channels with different blockers impairs ROS production by
neutrophils in a concentration-dependent way [40,44,52,55]). Fur-
thermore knock-out mice for the Hv1 proton channels show a se-
vere reduction in ROS production compared to WT [52].
Taken together these results make proton channels the best
candidates as charge compensators in activated neutrophils and
eosinophils.
6. Chloride as charge compensation mechanism in microglial
cells
The scenario is quite different in microglia cells. The resting po-
tential of the brain immune system components is more hyperpo-
larized than that of lymphocytes. Neutrophils show an average
resting membrane potential of 20 mV [50], whereas the resting
membrane potential in microglia is on average around 70 mV,
both in cell culture [16,17] and in brain slices [14]. Depolarization
caused by Ab perfusion on microglial cultures brings the mem-
brane potential to around 40 mV (Fig. 3) [17]. This value is far
from the positive potential at which the proton current becomes
active. Since ROS production appears to be voltage dependent
[44], it is important for microglia to be hyperpolarized in order
to sustain efﬁcient superoxide generation. In these cells the chlo-
ride concentration sets the reversal potential for chloride at around
60 mV. This makes chloride the main ion available to counteract
the charge movement across the cell membrane at the membrane
voltage values reached after the oxidase activation. Potassium ions
could contribute as well to the charge balance but at 40 mV the
outward ﬂow of K current in physiological conditions is probably
insufﬁcient to accomplish this duty [14]. The proton current does
not seem to be involved in this process either. As we mentioned
before, the activation of proton current occurs at positive poten-
tials. In addition, proton current inhibitors do not affect the mem-
brane potential of activated microglia [17]. However, we cannot
rule out the possibility that the proton current could be turned
on during a strong depolarization of microglia but this prospect
is unlikely caused by Ab stimulation. It is legitimate to ask how,
in the absence of a proton current, the cell could control the de-
crease of pH that comes naturally with the accumulation of pro-
tons due to the activity of the NADPH oxidase. De Simoni and
colleagues suggest that, considering the approximate volume of a
microglial cell and an electron current of approximately 30 pA
generated by the oxidases [41], the cell would acidify at a rate of
approximately of 0.5 U/min. This change of pH could be easily
accommodated by the exchangers that are in place to regulate
the pH in microglia cells: Na/HCO3 and Na/H transporters [54].
As mentioned above, CLIC1 insertion into the plasma membrane
increases in acidic pH [28,27]. Thus, the initial acidiﬁcation mightcontribute, together with the oxidation, to bring CLIC1 into the
plasma membrane. While the exchanger slowly works returning
the pH to physiological values, CLIC1 exerts its role by setting
the membrane potential, allowing an optimal ROS production.
Finally, it is important to mention that Ab deposits in AD brain
are rich in zinc [56] one of the most common inhibitors of proton
channels. Zinc shifts the activation threshold of proton current to
more positive values. This further weakens the possibility of an
involvement of these channels in the regulation of microglia cells’
membrane potential following activation of the NADPH oxidase in
physiological conditions. The peculiar characteristics of the CLIC1
protein is to translocate in the membrane. To our knowledge this
is the only case of a complex protein that works as a sensor of cyto-
plasmic conditions and, by rearranging its structure, become itself
a functional effector. However, even if there are strong data sup-
porting the protein insertion into the membrane [16,17,26], we
have no hints about the possibility that this mechanism is revers-
ible. Further investigations must elucidate this important aspect to
understand if CLIC1 protein represent not only the trigger, but also
the off signal once the redox balance is back to normal.
The CLIC1-mediated current is promptly followed by a DIDS-
sensitive current (Fig. 2d). This current is mediated by chloride
channels resident into the plasma membrane, possibly members
of the ClC family, more likely a chloride stretch activated channel.
The DIDS-sensitive current is always present during microglia
activation by different agents [17]. The peculiarity of Ab stimula-
tion is to trigger more IAA94 sensitive current than DIDS sensitive
(Fig. 2d). Previous experiments demonstrated that Ab perfusion of
CLIC1 siRNA transfected microglia fails to increase membrane con-
ductance [17,30]. This suggests that the DIDS component is a con-
sequence of CLIC1 activation. One possible mechanism is that
CLIC1, during its translocation to the cell membrane, not only
forms an ion channel, but also stimulates other chloride conduc-
tances. A second hypothesis is that the functional expression of
CLIC1 chloride current induces the activity of other chloride chan-
nels resident in the membrane. Internal chloride concentration, for
example, modulates many chloride channels [57]. Previous studies
have proposed an involvement of stretch-activated chloride chan-
nels as mechanisms of charge compensation following the activa-
tion of the NADPH oxidase induced by PMA in microglia cells [5].
This is not a surprise considering the role of the chloride perme-
ability system in the regulation of cell volume.
The statement that is important to highlight is that, during
external stimuli that change the redox state of the cytoplasm CLIC1
works ﬁrst as a redox sensor. By releasing GSH, it modiﬁes its
structure and colonizes the plasma membrane. Here, by forming
a chloride permeability, it acquires the function of an executor.
Its functional expression, promotes an increase of membrane chlo-
ride permeability allowing a sustained ROS production.
7. Conclusions and remarks
The main question still open about the components of the CLIC
protein family and about CLIC1 in particular is their physiological
role. As we describe in this review, it is accepted that CLIC1 protein
colonizes the cell membrane following changes in cytoplasmic
condition. It is also accepted that this interaction causes an in-
crease of membrane permeability, mainly due to anion ﬂux
[17,16]. According with several studies, CLIC1 is certainly involved
with the cell cycle [30], ROS production [22,17,16] and has a close
relation with cytoskeletal proteins [32]. However, in a recent pub-
lication, Breit and colleagues showed that CLIC1 knock-out mice
have only ‘‘a mild platelet dysfunction characterized by prolonged
bleeding times and decreased platelet activation in response to aden-
osine diphosphate stimulation linked to P2Y(12) receptor signaling”
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mechanism in clic1()/() mice. It is also likely that the functional
role of the CLIC1 protein is only evident in particular conditions,
such as during pathological states or during chronic stress condi-
tions. A possible strategy to face this problem will be to generate
tissue speciﬁc conditional KO mice or to work in speciﬁc organism
regions with CLIC1 RNA interference.
Another open issue remains the role of the protein in biological
membranes. From a functional point of view, the possibility that
CLIC1 itself forms an ionic channel is more an academic than a sub-
stantial question. CLIC1 activation, acting as a second messenger or
directly forming an ionic channel, causes an increase of chloride
permeability of the membrane and this is unequivocal. The molec-
ular nature of the chloride permeability will certainly prove impor-
tant for drug development once CLIC1 will be deﬁnitely recognized
as a pharmacological target. Ion channels have been particularly
useful therapeutic targets, especially for the development of drugs
acting on the CNS. In this context, the identiﬁcation between CLIC1
protein and the chloride ionic pathway will be fundamental. The
potential speciﬁc role of CLIC1 during pathological states, as the
last paper from Breit suggests [16], and its main role in oxidative
processes prompted by amyloid b in AD, makes it a better tool to
interfere with the course of these diseases without interfering with
the physiological functions of other chloride channels in the CNS.
The big picture about CLIC1 role in the cell physiology is still
missing several pieces. The most obscure question concerns the
protein function once localized in the membranes of the nuclear
envelope. An arduous hypothesis is the involvement of CLIC1 in
the nuclear envelope parcellization during the cell cycle. Since its
ability to increase chloride membrane permeability, CLIC1 inser-
tion in the nuclear membranes could move water in the nuclear
cisterns participating in the formation of pre-mitotic vesicles of
the envelope.
A totally unresolved issue is ﬁnally the role of CLIC1 in the cyto-
plasmic compartment. It is plausible that CLIC1 is involved in the
intracellular redox balance given the high afﬁnity of the protein
for reduced glutathione. Future studies should be focused at
uncovering the cytoplasmic role of CLIC1 for its probable involve-
ment in several biochemical intracellular pathways.
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